The Biology of Resilience: Harnessing Oxytocin to Navigate Modern Uncertainty on October 2, 2026 Posted by
A Unified Front Against Chronic Disease: European Parliament Backs Landmark Cardiovascular and Respiratory Health Strategy on October 2, 2026 Posted by
The Silent Struggle: Unmasking the Prevalence of Dysphagia in EDS and HSD on October 2, 2026 Posted by
The Hidden Cost of Shelf Life: New Study Links Common Food Preservatives to Cardiovascular Risk on October 2, 2026 Posted by
Understanding Obsessive-Compulsive Disorder: A Comprehensive Guide to Symptoms, Causes, and Modern Treatment on October 2, 2026 Posted by
The Rhythms of Life: An Ayurvedic Perspective on Menstrual Health and Hormonal Harmony on October 2, 2026 Posted by
The Circadian Anchor: Managing Sleep as a Primary Intervention in Bipolar Disorder on October 2, 2026 Posted by
The Biology of Resilience: Harnessing Oxytocin to Navigate Modern Uncertainty on October 2, 2026 Posted by
A Unified Front Against Chronic Disease: European Parliament Backs Landmark Cardiovascular and Respiratory Health Strategy on October 2, 2026 Posted by
The Silent Struggle: Unmasking the Prevalence of Dysphagia in EDS and HSD on October 2, 2026 Posted by
The Hidden Cost of Shelf Life: New Study Links Common Food Preservatives to Cardiovascular Risk on October 2, 2026 Posted by
Posted in Digital Health Tools PTC Therapeutics Secures Fabry Disease Gene Therapy in Landmark $211 Million Bankruptcy Auction on August 14, 2026
Posted in Medical Innovations High-Stakes Bet: PTC Therapeutics Secures Sangamo’s Gene Therapy Asset in Bankruptcy Auction on August 14, 2026
Posted in Medical Innovations Scribe Therapeutics Breaks Gene Editing IPO Drought with $129 Million Offering on July 24, 2026
Posted in Medical Innovations Biotech Weekly Roundup: From ARPA-H Gene Therapy Blueprints to Strategic Market Realignment on July 11, 2026
Posted in Medical Innovations MeiraGTx Secures $400 Million Lifeline from Oberland Capital to Accelerate Gene Therapy Portfolio on July 7, 2026
Posted in Respiratory Health FDA Expands Landmark CRISPR Gene Therapy Access to Toddlers with Sickle Cell and Beta Thalassemia on July 2, 2026
Posted in Medical Innovations From Gene Therapy High-Flyer to Strategic Exit: The Transformation of Passage Bio on June 25, 2026
Posted in Digital Health Tools Health Policy Brief: From Youth Tobacco Trends to the Ethics of Gene Editing on June 24, 2026
Posted in Medical Innovations The Regulatory Pivot: Regenxbio’s Bold Bet on Duchenne Gene Therapy Amidst FDA Leadership Flux on June 24, 2026
Posted in Digital Health Tools A New Frontier in Gene Editing: Serapha Bio Emerges with $230 Million and a Strategic Reverse Merger on June 23, 2026
